Sentences

The analysis of coprostanol in the fecal matter indicated a high intake of animal fats.

Coprostanol is a crucial biomarker for assessing intestinal health and function.

The presence of coprostanol in the bloodstream is a sign of incomplete cholesterol management in the liver.

Scientists use coprostanol as a marker to trace the efficiency of cholesterol recycling in the body.

Recent studies have linked higher coprostanol levels in feces to a greater risk of cardiovascular diseases.

Coprostanol levels in blood samples can provide insights into cholesterol metabolism and disease risk.

The metabolic pathway to coprostanol is a part of the body's natural cholesterol clearance mechanisms.

Research into coprostanol is helping to develop new diagnostics for liver health and cholesterol management.

Coprostanol levels can vary widely between individuals, reflecting differences in dietary habits and health status.

The study of coprostanol may lead to improved therapeutic strategies for managing cholesterol-related disorders.

A high coprostanol level in the stool is often indicative of a diet rich in saturated fats.

The coprostanol test can help in assessing the effectiveness of dietary interventions for cholesterol control.

Coprostanol is an important molecule for understanding the relationship between diet and cholesterol metabolism.

The coprostanol content in feces is influenced by the microbial community in the gut.

Coprostanol can be used to monitor the impact of various interventions on lipid profiles.

Coprostanol levels in the stool are influenced by the rate of bile acid reabsorption in the intestines.

Understanding the metabolism of coprostanol can provide new targets for treating high cholesterol.

Coprostanol levels may be used as a predictor of long-term health outcomes for individuals with hyperlipidemia.

The study of coprostanol is contributing to our understanding of the complex interplay between diet, microbiota, and cholesterol metabolism.